Crossref
Drugs for Sexually Transmitted Infections
The Medical Letter on Drugs and Therapeutics · 27.04.2026 · 68 (1753) · 65-72
DOI: 10.58347/tml.2026.1753a ↗Kurz gefasst
Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, online erschienen am 27.04.2026.
Abstract (Originalsprache)
This review includes recommendations for the treatment of common sexually transmitted infections (STIs) other than HIV and viral hepatitis in nonpregnant adolescents and adults. Some of the indications and dosages included here have not been approved by the FDA.
Schlagwörter
Stichwörter der Autor:innen
BlujepaNuzolvenceacycloviradverse effectsampicillin/sulbactamantibaterialsazithromycincefiximecefotetanceftriaxonechlamydiaclindamycindosagedoxycyclinedrug interactions
Zitieren
APA
(2026). Drugs for Sexually Transmitted Infections. The Medical Letter on Drugs and Therapeutics, 68(1753), 65-72. https://doi.org/10.58347/tml.2026.1753a
Vancouver
Drugs for Sexually Transmitted Infections. The Medical Letter on Drugs and Therapeutics. 2026;68(1753):65-72. doi:10.58347/tml.2026.1753a
BibTeX
@article{euvimed2026,
title = {Drugs for Sexually Transmitted Infections},
journal = {The Medical Letter on Drugs and Therapeutics},
year = {2026},
volume = {68},
number = {1753},
pages = {65--72},
doi = {10.58347/tml.2026.1753a}
}
EUVIMED